Showing all published months. Partner preview tables include up to 20 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 20 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| United States | $4.2B | 26.5% |
| Australia | $1.2B | 7.8% |
| South Korea | $994.7M | 6.3% |
| United Kingdom | $755.3M | 4.8% |
| Poland | $608.3M | 3.8% |
| Philippines | $530.3M | 3.4% |
| Hong Kong | $523.5M | 3.3% |
| Netherlands | $454.3M | 2.9% |
| Italy | $423.9M | 2.7% |
| Malaysia | $410.7M | 2.6% |
| Nigeria | $304.3M | 1.9% |
| Brazil | $274.2M | 1.7% |
| Thailand | $246.5M | 1.6% |
| Germany | $238.1M | 1.5% |
| Slovenia | $220.1M | 1.4% |
| France | $216.8M | 1.4% |
| Belgium | $214.1M | 1.4% |
| Singapore | $192.9M | 1.2% |
| Macao | $179.4M | 1.1% |
| Japan | $157.1M | 1.0% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| United States | $80.8M | 26.3% |
| Australia | $21.7M | 7.1% |
| Belgium | $16.6M | 5.4% |
| South Korea | $14.9M | 4.9% |
| United Kingdom | $11.1M | 3.6% |
| Hong Kong | $10.7M | 3.5% |
| Malaysia | $10.6M | 3.4% |
| Philippines | $9.8M | 3.2% |
| Poland | $8.7M | 2.8% |
| Netherlands | $8.5M | 2.7% |
| Slovenia | $6.4M | 2.1% |
| Macao | $5.7M | 1.8% |
| France | $5.4M | 1.8% |
| New Zealand | $5M | 1.6% |
| Germany | $4.3M | 1.4% |
| Brazil | $4.2M | 1.4% |
| Peru | $3.7M | 1.2% |
| Italy | $3.6M | 1.2% |
| India | $3.3M | 1.1% |
| Nigeria | $3.1M | 1.0% |
| Year | Export value |
|---|---|
| 2021 | $2.6B |
| 2022 | $2.7B |
| 2023 | $2.6B |
| 2024 | $2.8B |
| 2025 | $3.1B |
| 2026 | $1.9B |
Public data shows up to 20 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.
HS 30049090 is also written 3004.90.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Pharmaceutical preparations for therapeutic or prophylactic retail sale that do not fall under Chinese-type medicines or other specifically named categories. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of mixed or unmixed products, nes, in measured doses or in retail packings (HS 30049090) Export Data." https://chinadata.live/china-trade/hs8/30049090/
HS 30049090 is also written 3004.90.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Pharmaceutical preparations for therapeutic or prophylactic retail sale that do not fall under Chinese-type medicines or other specifically named categories. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of mixed or unmixed products, nes, in measured doses or in retail packings (HS 30049090) Export Data." https://chinadata.live/china-trade/hs8/30049090/
China exported $3.2B of medicaments of mixed or unmixed products, nes, in measured doses or in retail packings in the twelve months to July 2026, averaging $270M per month, based on official China customs statistics (HS 30049090).
Pharmaceutical preparations for therapeutic or prophylactic retail sale that do not fall under Chinese-type medicines or other specifically named categories.
United States, Australia and South Korea together account for 41% of the published total, out of 144 trading partners on record.
Annual exports grew by 18% between 2021 and 2025, from $2.6B to $3.1B.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.